EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Doxifluridine promotes host longevity through bacterial metabolism

Rui Wei, Yuling Peng, Yamei Luo, Xinyuan Wang iD, Zhenzhong Pan, Ran Zhou iD, Huan Yang, Zongyao Huang, Yaojia Liu, Lunzhi Dai, Yuan Wang iD, Yan Zhang iD

PLOS Genetics · 31.03.2025 · 21 (3) · e1011648

DOI: 10.1371/journal.pgen.1011648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 31.03.2025. Verfasst von Rui Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, Chin…. Hauptthemen laut MEDLINE: Longevity, Caenorhabditis elegans, Floxuridine, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aging is associated with alternative splicing (AS) defects that have broad implications on aging-associated disorders. However, which drug(s) can rescue age-related AS defects and extend lifespan has not been systematically explored. We performed large-scale compound screening in C. elegans using a dual-fluorescent splicing reporter system. Among the top hits, doxifluridine, a fluoropyrimidine derivative, rescues age-associated AS defects and extends lifespan. Combining bacterial DNA sequencing, proteomics, metabolomics and the three-way screen system, we further revealed that bacterial ribonucleotide metabolism plays an essential role in doxifluridine conversion and efficacy. Furthermore, doxifluridine increases production of bacterial metabolites, such as linoleic acid and agmatine, to prolong host lifespan. Together, our results identify doxifluridine as a potent lead compound for rescuing aging-associated AS defects and extending lifespan, and elucidate drug’s functions through complex interplay among drug, bacteria and host.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LongevityCaenorhabditis elegansFloxuridineBacteriaAnimalsAlternative SplicingAging

Substanzen

Floxuridine

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Proteomics-Metabolomics Platform of Core Facilities, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Tianfu Jincheng Laboratory, Frontiers Medical Center, Chengdu, Sichuan, China.

ORCID-Profile: Xinyuan Wang, Ran Zhou, Yuan Wang, Yan Zhang

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province

Zitieren

APA

Wei, R., Peng, Y., Luo, Y., Wang, X., Pan, Z., Zhou, R., Yang, H., Huang, Z., Liu, Y., Dai, L., Wang, Y., & Zhang, Y. (2025). Doxifluridine promotes host longevity through bacterial metabolism. PLOS Genetics, 21(3), e1011648. https://doi.org/10.1371/journal.pgen.1011648

Vancouver

Wei R, Peng Y, Luo Y, Wang X, Pan Z, Zhou R, et al. Doxifluridine promotes host longevity through bacterial metabolism. PLOS Genetics. 2025;21(3):e1011648. doi:10.1371/journal.pgen.1011648

BibTeX
@article{Wei2025,
  author = {Wei, Rui and Peng, Yuling and Luo, Yamei and Wang, Xinyuan and Pan, Zhenzhong and Zhou, Ran and Yang, Huan and Huang, Zongyao and Liu, Yaojia and Dai, Lunzhi and Wang, Yuan and Zhang, Yan},
  title = {Doxifluridine promotes host longevity through bacterial metabolism},
  journal = {PLOS Genetics},
  year = {2025},
  volume = {21},
  number = {3},
  pages = {e1011648},
  doi = {10.1371/journal.pgen.1011648}
}
Kostenlos starten →